A recent decision by the Federal Drug Administration to approve a prescription drug for self-identified Blacks has been met with mixed reviews. While some established medical organizations approve of the drug’s use, the implications of practicing medicine based on patients' racial identities is being questioned by other doctors. Dr. Gregg Bloche, a law professor at Georgetown University and a medical doctor, tells Tony Brown why he feels that the decision to target Black people (at a cost of $400 for a month's supply) might have been predicated on business rather than any reliable science. (2820)
You may also like
The AIDS Maverick
3.75K Views0 Likes
Virologist Dr. Peter Duesberg emerged has one of the scientific community’s brightest talents when he discovered the viral gene that can cause cancer. This program examines his research and his controversial stance on...
Hunting The Virus Hunter – Pt. 1
2.22K Views0 Likes
Dr. Peter Duesberg (renowned virologist) and Elinor Burkett (Miami Herald, reporter) discuss HIV, AIDS and AZT. 1410
Hunting The Virus Hunter – Pt. 2
1.88K Views0 Likes
Dr. Peter Duesberg (renowned virologist) and Elinor Burkett (Miami Herald, reporter) discuss HIV, AIDS and AZT. 1411